[Cellular and humoral immunity in atopic dermatitis]. 1998

N Mutevelić-Arslanagić
Dermatoveneroloska klinika Klinicki centar Sarajevo.

In vitro tests of cellular and humoral immunity were analysed by: T and B lymphocytes, T4 and T8 lymphocyte subsets, lymphocyte blast transformation tests with unspecified mitogenom--phytohemaglutinin, C3 and C4 components of the complement and circulating immune complexes at patients from 6 to 54 years old who suffered from atopic dermatitis without any other clinical symptom of atopy (so called "pure" atopic dermatitis). Parameters of cellular and humoral immunity were analysed in the active and quiescent phase of illness. The results were statistically analyzed by Student's "t" test and compared with results of the control group. In the active phase of illness IgE level in serum was statistically and significantly increased while other parameters of humoral and cellular immunity did not significantly differ in relation to control group. In certain percentage in the active phase of illness decreased values of serum's IgA, C3 component of the complement, number of T8 lymphocytes and lymphocytes transformation test were found as well as the increase of circulating immune complexes IgG, IgM and B lymphocyte. All laboratory tests were repeated in the quiescent phase of illness, when patients had no changes on the skin in at least one month period. It was found that some increased values of serum's IgE were normalised in the quiescent phase of illness. Besides increased serum's IgE in the active phase of illness, it was not possible to determine cellular and humoral immunity defect by tests in vitro at "pure" atopic dermatitis.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

N Mutevelić-Arslanagić
January 2014, Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994),
N Mutevelić-Arslanagić
January 1983, Przeglad dermatologiczny,
N Mutevelić-Arslanagić
May 1987, The British journal of dermatology,
N Mutevelić-Arslanagić
June 1975, The British journal of dermatology,
N Mutevelić-Arslanagić
January 1980, Przeglad dermatologiczny,
N Mutevelić-Arslanagić
December 2016, Archivum immunologiae et therapiae experimentalis,
N Mutevelić-Arslanagić
March 1978, Archives of dermatology,
N Mutevelić-Arslanagić
January 2011, Current problems in dermatology,
Copied contents to your clipboard!